{"pmid":32127123,"title":"Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.","text":["Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.","A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.","Euro Surveill","Bordi, Licia","Nicastri, Emanuele","Scorzolini, Laura","Di Caro, Antonino","Capobianchi, Maria Rosaria","Castilletti, Concetta","Lalle, Eleonora","On Behalf Of Inmi Covid-Study Group And Collaborating Centers","32127123"],"abstract":["A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases."],"journal":"Euro Surveill","authors":["Bordi, Licia","Nicastri, Emanuele","Scorzolini, Laura","Di Caro, Antonino","Capobianchi, Maria Rosaria","Castilletti, Concetta","Lalle, Eleonora","On Behalf Of Inmi Covid-Study Group And Collaborating Centers"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32127123","week":"202010|Mar 02 - Mar 08","doi":"10.2807/1560-7917.ES.2020.25.8.2000170","keywords":["SARS-CoV-2","differential diagnosis","rapid molecular assay","respiratory pathogens"],"source":"PubMed","locations":["Italy","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1661359647666208769,"score":6.7365713,"similar":[{"pmid":32022275,"title":"The first two cases of 2019-nCoV in Italy: Where they come from?","text":["The first two cases of 2019-nCoV in Italy: Where they come from?","A novel Coronavirus, 2019-nCoV, has been identified as the causal pathogen of an ongoing epidemic, with the first cases reported in Wuhan, China, last December 2019, and has since spread to other countries worldwide, included Europe and very recently Italy. In this short report, phylogenetic reconstruction was used to better understand the transmission dynamics of the virus from its first introduction in China focusing on the more recent evidence of infection in a couple of Chinese tourists arrived in Italy on 23rd January 2020 and labeled as Coronavirus Italian cases. A maximum clade credibility tree has been built using a dataset of 54 genome sequences of 2019-nCoV plus two closely related bat strains (SARS-like CoV) available in GenBank. Bayesian time-scaled phylogenetic analysis was implemented in BEAST 1.10.4. The Bayesian phylogenetic reconstruction showed that 2019-2020 nCoV firstly introduced in Wuhan on 25 November 2019, started epidemic transmission reaching many countries worldwide, including Europe and Italy where the two strains isolated dated back 19 January 2020, the same that the Chinese tourists arrived in Italy. Strains isolated outside China were intermixed with strains isolated in China as evidence of likely imported cases in Rome, Italy, and Europe, as well. In conclusion, this report suggests that further spread of 2019-nCoV epidemic was supported by human mobility and that quarantine of suspected or diagnosed cases is useful to prevent further transmission. Viral genome phylogenetic analysis represents a useful tool for the evaluation of transmission dynamics and preventive action.","J Med Virol","Giovanetti, Marta","Benvenuto, Domenico","Angeletti, Silvia","Ciccozzi, Massimo","32022275"],"abstract":["A novel Coronavirus, 2019-nCoV, has been identified as the causal pathogen of an ongoing epidemic, with the first cases reported in Wuhan, China, last December 2019, and has since spread to other countries worldwide, included Europe and very recently Italy. In this short report, phylogenetic reconstruction was used to better understand the transmission dynamics of the virus from its first introduction in China focusing on the more recent evidence of infection in a couple of Chinese tourists arrived in Italy on 23rd January 2020 and labeled as Coronavirus Italian cases. A maximum clade credibility tree has been built using a dataset of 54 genome sequences of 2019-nCoV plus two closely related bat strains (SARS-like CoV) available in GenBank. Bayesian time-scaled phylogenetic analysis was implemented in BEAST 1.10.4. The Bayesian phylogenetic reconstruction showed that 2019-2020 nCoV firstly introduced in Wuhan on 25 November 2019, started epidemic transmission reaching many countries worldwide, including Europe and Italy where the two strains isolated dated back 19 January 2020, the same that the Chinese tourists arrived in Italy. Strains isolated outside China were intermixed with strains isolated in China as evidence of likely imported cases in Rome, Italy, and Europe, as well. In conclusion, this report suggests that further spread of 2019-nCoV epidemic was supported by human mobility and that quarantine of suspected or diagnosed cases is useful to prevent further transmission. Viral genome phylogenetic analysis represents a useful tool for the evaluation of transmission dynamics and preventive action."],"journal":"J Med Virol","authors":["Giovanetti, Marta","Benvenuto, Domenico","Angeletti, Silvia","Ciccozzi, Massimo"],"date":"2020-02-06T11:00:00Z","year":2020,"_id":"32022275","week":"20206|Feb 03 - Feb 09","doi":"10.1002/jmv.25699","keywords":["engineering and technology","epidemiology","infection","macromolecular design"],"source":"PubMed","locations":["Italian","Chinese","Wuhan","Bayesian","China","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1661359647206932480,"score":132.72337},{"pmid":32153167,"title":"[The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].","text":["[The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].","Novel coronavirus pneumonia was novel coronavirus infection that has dominated pulmonary infection since December 2019. The main manifestations were fever, dry cough, shortness of breath, normal or leukopenia in peripheral blood and changes in chest CT and in severe cases, multiple organ failure might occur. The National Health Commission, PRC has revised the consensus on diagnosis and treatment seven times in a short period of time, indicating the growing understanding of the disease. Patients with novel coronavirus pneumonia usually had history of travelling or living in the epidemic area including Wuhan within 14 days before onset, or have been exposed to patients who had fever or respiratory symptoms from the epidemic area, or had clustering diseases. However, novel coronavirus pneumonia was becoming more and more blurred after vanishing epidemic. The diagnosis and differential diagnosis of novel coronavirus pneumonia was facing challenges not only because of large number of tourists increasing dramatically after the relieving of epidemic, but also patients with other diseases return from different areas to search for medical care. In this article, the clinical and chest imaging features of the novel coronavirus pneumonia were reviewed and compared with other infections and non-infectious diffuse pulmonary diseases. We were trying to find the similarities and differences among them, and to identify clues to the diagnosis of novel coronavirus pneumonia, so as to ensure accurate diagnosis and treatment.","Zhonghua Jie He He Hu Xi Za Zhi","Tian, X L","Peng, M","Wang, H P","Cai, B Q","Xu, W B","Zhu, Y J","Li, T S","Zhu, H D","Song, L","Wang, M Z","Zhang, L","Shi, J H","32153167"],"abstract":["Novel coronavirus pneumonia was novel coronavirus infection that has dominated pulmonary infection since December 2019. The main manifestations were fever, dry cough, shortness of breath, normal or leukopenia in peripheral blood and changes in chest CT and in severe cases, multiple organ failure might occur. The National Health Commission, PRC has revised the consensus on diagnosis and treatment seven times in a short period of time, indicating the growing understanding of the disease. Patients with novel coronavirus pneumonia usually had history of travelling or living in the epidemic area including Wuhan within 14 days before onset, or have been exposed to patients who had fever or respiratory symptoms from the epidemic area, or had clustering diseases. However, novel coronavirus pneumonia was becoming more and more blurred after vanishing epidemic. The diagnosis and differential diagnosis of novel coronavirus pneumonia was facing challenges not only because of large number of tourists increasing dramatically after the relieving of epidemic, but also patients with other diseases return from different areas to search for medical care. In this article, the clinical and chest imaging features of the novel coronavirus pneumonia were reviewed and compared with other infections and non-infectious diffuse pulmonary diseases. We were trying to find the similarities and differences among them, and to identify clues to the diagnosis of novel coronavirus pneumonia, so as to ensure accurate diagnosis and treatment."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Tian, X L","Peng, M","Wang, H P","Cai, B Q","Xu, W B","Zhu, Y J","Li, T S","Zhu, H D","Song, L","Wang, M Z","Zhang, L","Shi, J H"],"date":"2020-03-11T11:00:00Z","year":2020,"_id":"32153167","week":"202011|Mar 09 - Mar 15","doi":"10.3760/cma.j.cn112147-20200221-00136","keywords":["Clinical features","Coronavirus disease 2019","Diagnosis, differential","Tomography, X-Ray computed"],"source":"PubMed","locations":["PRC","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1661359647828738050,"score":112.06723},{"pmid":32156330,"title":"Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020.","text":["Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020.","The need for timely establishment of diagnostic assays arose when Germany was confronted with the first travel-associated outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Europe. We describe our laboratory experiences during a large contact tracing investigation, comparing previously published real-time RT-PCR assays in different PCR systems and a commercial kit. We found that assay performance using the same primers and probes with different PCR systems varied and the commercial kit performed well.","Euro Surveill","Konrad, Regina","Eberle, Ute","Dangel, Alexandra","Treis, Bianca","Berger, Anja","Bengs, Katja","Fingerle, Volker","Liebl, Bernhard","Ackermann, Nikolaus","Sing, Andreas","32156330"],"abstract":["The need for timely establishment of diagnostic assays arose when Germany was confronted with the first travel-associated outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Europe. We describe our laboratory experiences during a large contact tracing investigation, comparing previously published real-time RT-PCR assays in different PCR systems and a commercial kit. We found that assay performance using the same primers and probes with different PCR systems varied and the commercial kit performed well."],"journal":"Euro Surveill","authors":["Konrad, Regina","Eberle, Ute","Dangel, Alexandra","Treis, Bianca","Berger, Anja","Bengs, Katja","Fingerle, Volker","Liebl, Bernhard","Ackermann, Nikolaus","Sing, Andreas"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32156330","week":"202011|Mar 09 - Mar 15","doi":"10.2807/1560-7917.ES.2020.25.9.2000173","keywords":["COVID-19","Corona Virus","Infectious disease","Laboratory Diagnostics","Molecular Testing","Real-Time PCR","SARS-CoV-2","outbreaks"],"source":"PubMed","locations":["Bavaria, Germany","Germany"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Diagnosis"],"weight":1,"_version_":1661359647852855296,"score":110.71761},{"pmid":32146445,"title":"Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.","text":["Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.","As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.","J Infect Dev Ctries","Porcheddu, Rossella","Serra, Caterina","Kelvin, David","Kelvin, Nikki","Rubino, Salvatore","32146445"],"abstract":["As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease."],"journal":"J Infect Dev Ctries","authors":["Porcheddu, Rossella","Serra, Caterina","Kelvin, David","Kelvin, Nikki","Rubino, Salvatore"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32146445","week":"202011|Mar 09 - Mar 15","doi":"10.3855/jidc.12600","keywords":["Case Fatality Rates","Italy","Novel coronavirus COVID-19","SARS-CoV-19","outbreak"],"source":"PubMed","locations":["Italy","Milan","China","Veneto"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647784697856,"score":96.65757},{"pmid":32134909,"title":"Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020.","text":["Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020.","In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact(dagger) with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.","MMWR Morb Mortal Wkly Rep","Burke, Rachel M","Midgley, Claire M","Dratch, Alissa","Fenstersheib, Marty","Haupt, Thomas","Holshue, Michelle","Ghinai, Isaac","Jarashow, M Claire","Lo, Jennifer","McPherson, Tristan D","Rudman, Sara","Scott, Sarah","Hall, Aron J","Fry, Alicia M","Rolfes, Melissa A","32134909"],"abstract":["In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact(dagger) with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission."],"journal":"MMWR Morb Mortal Wkly Rep","authors":["Burke, Rachel M","Midgley, Claire M","Dratch, Alissa","Fenstersheib, Marty","Haupt, Thomas","Holshue, Michelle","Ghinai, Isaac","Jarashow, M Claire","Lo, Jennifer","McPherson, Tristan D","Rudman, Sara","Scott, Sarah","Hall, Aron J","Fry, Alicia M","Rolfes, Melissa A"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32134909","week":"202010|Mar 02 - Mar 08","doi":"10.15585/mmwr.mm6909e1","source":"PubMed","locations":["- United States","United States","Wuhan","China"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647697666048,"score":96.03302}]}